ALTEROME THERAPEUTICS
Alterome Therapeutics is a precision oncology biotech developing alteration-specific therapeutics to address high value and validated oncogenic drivers.
ALTEROME THERAPEUTICS
Industry:
Biopharma Biotechnology Pharmaceutical
Founded:
2021-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.alterome.com
Total Employee:
11+
Status:
Active
Contact:
650-493-9300
Total Funding:
231 M USD
Technology used in webpage:
Google Google Cloud Microsoft Microsoft Azure Microsoft Azure US West Region Bamboo HR
Similar Organizations
Arrakis Therapeutics
Arrakis Therapeutics is a biopharmaceutical developing drugs for neurological disorders and other diseases.
Eidos Therapeutics
Eidos Therapeutics is a clinical-stage biotech company developing novel, genetically targeted therapies to improve the lives of patients.
Enalare Therapeutics
Enalare Therapeutics is a clinical stage biopharmaceutical company dedicated to developing novel therapies.
NephroDI Therapeutics
NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney.
Paracrine
Paracrine is a biopharmaceutical company provided development of stem exosome for regenerative medicine.
Reata Pharmaceuticals
Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.
Simcha Therapeutics
Simcha Therapeutics is a biopharmaceutical company developing engineered cytokine immunotherapy for cancer.
Sirnaomics
Sirnaomics is a biopharmaceutical company developing therapeutics for critical human diseases by using RNA interference technology.
Current Advisors List
Board_member
Board_member
2024-04-03
Board_member
Board_member
2024-04-03
Board_member
Current Employees Featured
Andrew S. Chi Chief Medical Officer @ Alterome Therapeutics
Chief Medical Officer
2023-01-01
Eric A Murphy CEO, CSO, and Co-Founder @ Alterome Therapeutics
CEO, CSO, and Co-Founder
2021-12-01
Sanjeev Thohan Senior Vice President Nonclinical Research @ Alterome Therapeutics
Senior Vice President Nonclinical Research
2023-02-01
Founder
Investors List
Driehaus Capital Management
Driehaus Capital Management investment in Series B - Alterome Therapeutics
Goldman Sachs
Goldman Sachs investment in Series B - Alterome Therapeutics
Boxer Capital
Boxer Capital investment in Series B - Alterome Therapeutics
Colt Ventures
Colt Ventures investment in Series B - Alterome Therapeutics
Digitalis Ventures
Digitalis Ventures investment in Series B - Alterome Therapeutics
Invus
Invus investment in Series B - Alterome Therapeutics
Vida Ventures
Vida Ventures investment in Series B - Alterome Therapeutics
Blue Owl
Blue Owl investment in Series B - Alterome Therapeutics
Nextech Invest
Nextech Invest investment in Series B - Alterome Therapeutics
Canaan Partners
Canaan Partners investment in Series B - Alterome Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2023-08-23 | Alterome Therapeutics Welcomes Andrew S. Chi, M.D., Ph.D., as Chief Medical Officer |
Official Site Inspections
http://www.alterome.com
- Host name: 132.89.139.34.bc.googleusercontent.com
- IP address: 34.139.89.132
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Alterome Therapeutics"
Alterome Therapeutics - Crunchbase Company Profile …
Organization. Alterome Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ...See details»
Alterome Therapeutics, Inc | LinkedIn
Alterome Therapeutics, Inc. is a clinical-stage precision oncology biotech developing alteration-specific therapeutics to address high value and validated oncogenic drivers. We are a team …See details»
Alterome Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
AKTive-001 is a Phase 1/1b study of ALTA2618 in adults with AKT1 E17K-mutant solid tumors ALTA2618 is the first clinical mutant-selective inhibitor of AKT SAN DIEGO, CA, USA I …See details»
Alterome Therapeutics - Overview, News & Similar companies
Who is Alterome Therapeutics. Alterome Therapeutics, Inc. is a precision oncology biotech developing alteration-specific therapeutics to address high value and validated oncogen ic …See details»
Alterome Therapeutics Announces New Chief Executive Officer …
Apr 10, 2025 Alterome has raised more than $231 million in venture capital to date and is led by a team of precision oncology R&D leaders with a history of developing marketed oncology …See details»
Who We Are - Alterome
Community Work Building community. At Alterome, we are committed to giving back to our San Diego community. We are a proud Corporate Sponsor of Life Science Cares (LSC) San Diego, …See details»
San Diego's Alterome Therapeutics raised a $132M Series B
Apr 3, 2024 Co-Founder and CEO Eric Murphy describes what it was like raising the money in this environment, and delves into Alterome's programs, including AKT1 E17K and KRAS. ...See details»
Alterome Therapeutics, Inc - Founder Lodge
Alterome Therapeutics, Inc. is a precision oncology biotech developing alteration-specific therapeutics to address high value and validated oncogenic drivers. We are a team with …See details»
Alterome Therapeutics - workinbiotech.com
Alterome Therapeutics is focused on developing next-generation, small molecule targeted therapies for precision treatment of cancer. Their approach is centered around identifying and …See details»
Press releases Archives - Alterome
Oct 17, 2024 Alterome Therapeutics, Inc., a biopharmaceutical company pioneering the development of next generation, small molecule targeted therapies for the treatment of cancer, …See details»
Alterome Therapeutics, Inc Careers, Perks + Culture - Built In
Alterome Therapeutics, Inc. is a precision oncology biotech developing alteration-specific therapeutics to address high value and validated oncogenic drivers. We are a team with …See details»
Alterome Therapeutics - Funding, Financials, Valuation & Investors
Alterome Therapeutics is a biopharmaceutical company developing alteration-specific targeted therapies. New. Resources. Advanced Search. Start Free Trial . Talk With Sales. ... How much …See details»
What We Do - Alterome
The alterome, consisting of all the disease driving alterations in genes, remains largely undrugged. It has long been known that genetic alterations are oncogenic drivers. Several …See details»
Alterome Therapeutics - Contacts, Employees, Board Members
Alterome Therapeutics is a biopharmaceutical company developing alteration-specific targeted therapies. New. ... Experience the new Crunchbase, powered by AI . Experience the new …See details»
Contact Us - Alterome
Alterome Therapeutics 13480 Evening Creek Drive North, Suite 450, San Diego, CA 92128. info@alterome.comSee details»
Join Us - Alterome
Alterome Therapeutics, Inc. is an equal opportunity employer committed to building a diverse and inclusive organization. We measure each applicant, candidate and employee based on their …See details»
Eric Murphy, Ph.D. | Sidewinder Therapeutics
Dr. Murphy served as Chief Executive Officer and/or Chief Scientific Officer and led each organization from company formation through early clinical trials. His recent focus on next …See details»
Alterome Therapeutics Announces New Chief Executive Officer
Apr 10, 2025 Alterome Therapeutics, Inc. is a clinical-stage precision oncology biotechnology company developing alteration-specific therapeutics to address high-value and validated …See details»
The ‘OpenAI Files’ will help you understand how Sam ... - The Verge
2 days ago Two tech industry watchdog organizations released a research report called the OpenAI Files that covers OpenAI’s corporate structure, its restructuring to a for-profit …See details»
Programs - Alterome
Alterome is developing several next generation, small molecule targeted therapies for the treatment of cancer. Our pipeline features two clinical-stage programs currently in Phase 1/1b, …See details»